Pureheart Capital’s NOV NOV Stock Holding History

Pureheart Capital’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-209,000	Closed	-$2.77M	–	13
2025 Q3	$2.77M	Buy	+209,000	New	+$2.7M	0.31%	12

Other funds holding NOV

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Pureheart Capital's NOV Position: Q4 2025 in Review

Pureheart Capital sold out of NOV (NOV) in Q4 2025, closing a stake of 209,000 shares — an estimated $2.77M sold.

Pureheart Capital first reported a position in NOV in Q3 2025 and held it in 1 quarter. The position peaked at $2.77M in Q3 2025. 434 funds tracked by Wall St. Rank hold NOV as of Q4 2025.

Pureheart Capital reported no remaining NOV position as of Q4 2025 after selling out during the quarter.
Pureheart Capital sold 209,000 NOV shares in Q4 2025, an estimated $2.77M.
Pureheart Capital first reported a position in NOV in Q3 2025 and held it in 1 quarter.
Pureheart Capital's NOV position peaked at $2.77M in Q3 2025.
434 funds tracked by Wall St. Rank held NOV as of Q4 2025.

Based on Pureheart Capital's 13F filing for Q4 2025, filed 17 Feb 2026.